Amplifon Australia Opens Its Headquarters in Central Melbourne
New office building entrance Amplifon Australia Opens Its Headquarters in Central MelbourneMELBOURNE, Australia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Amplifon,...
Year: 2023
Affimed Announces Publication in the Journal mAbs on Leveraging FcRn-pH-HPLC as a Method to Select Bispecific Antibodies with Optimal Developability
By coupling the chromatography method FcRn-HPLC to a pH monitor, an optimized FcRn-pH-HPLC methodology was developed allowing correlation of antibodies’...
Actimed Therapeutics secures additional £4.75m funding in Series A extension round, almost doubling Series A proceeds
London, UK – 22 August 2023 Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on...
Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland
Strategic Partnership Aims to Revolutionize Cancer Screening and Enhance Healthcare Outcomes, Bringing Innovative Genetic Testing Solutions to Individuals Across PolandBERKELEY,...
Bredis Healthcare Awarded South Korean Government Grant for Advancing Early Diagnosis of Alzheimer’s Disease
Bredis Healthcare secures KRW 1.7 billion grant for advancing Alzheimer’s disease diagnosis from South Korean government’s Deep Tech TIPS programNovel...
Ultimovacs ASA Reports Second Quarter 2023 Financial Results and Provides General Business Update
Oslo, 22 August 2023: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces its...
Dr. Christian Brander and Dr. Mala Maini Join World-class Scientific Advisory Board of AstriVax
Christian Brander, Ph.D., is a leading expert on T cell responses to viral infections and brings an important blend of...
Dr. Lyudmila Sarder Receives Rave Reviews from Lakeland Regional Health and AdventHealth Cancer Institute for Research
❝The commendable efforts of Dr. Lyudmila Sarder and Dr. Sarfraz Ahmad in combating the financial barriers associated with cancer treatment...
Sibannac, Inc. Appoints Karl Gottschalk – Manufacturing Automation Engineer and Operational Expert – as CEO of its Subsidiary, Immersive Brand Concepts, Inc.
Scottsdale, Arizona--(Newsfile Corp. - August 22, 2023) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
Nexgenrx Announces Q2 2023 Quarterly Results (With Continued Revenue Growth), Consulting Agreement and Option Grant
TORONTO, ON / ACCESSWIRE / August 21, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its...
NextGen Healthcare Selected by Community Reach Center to Serve Mental Health, Substance Abuse, and Primary Care Needs
Colorado’s First Community Mental Health Center Adopts Complete Behavioral Health Solution to Advance CareREMOTE-FIRST COMPANY/DENVER--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq:...
Association for Pediatric Vision Announces a Free Vision Screening Training Offered Nationwide
TAMPA, FL / ACCESSWIRE / August 21, 2023 / The Association for Pediatric Vision, a program of Lions World Vision...
Talkdesk and Epic enter new collaboration with the launch of Epic’s Pals program
Industry-leader in electronic health record (EHR) software deepens collaboration with Talkdesk to co-innovate on integrated patient experience solutionsSAN FRANCISCO--(BUSINESS WIRE)--#CX--Talkdesk®,...
PicnicHealth Announces Entry into Market for Oncology-Focused Real-World Data
Company announces multi-year strategic partnership with AstraZeneca to accelerate early breast cancer evidence development and researchSAN FRANCISCO--(BUSINESS WIRE)--PicnicHealth, a patient-centered...
IRLAB Secures Full Ownership of the Mesdopetam Project and Continues Product Development
GOTHENBURG, SE / ACCESSWIRE / August 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for...
IRLAB Provides Update on Mesdopetam’s Phase IIb Study Data and the Plans Toward Phase III
GOTHENBURG, SE / ACCESSWIRE / August 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for...
AlayaCare Welcomes Seasoned Executive Rhonda Bosch as Senior Vice President of Customer Success
TORONTO, ON / ACCESSWIRE / August 21, 2023 / AlayaCare, an industry-leading end-to-end platform for home-based care today, announced that...
The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricides
SHELTON, CT / ACCESSWIRE / August 21, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development...
Bethany L. Sensenig Joins Supernus’ Board of Directors
ROCKVILLE, Md., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023
INPEFA recently approved by FDA for treatment of heart failure THE WOODLANDS, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Lexicon...